Dental Market
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Dental Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Dental Market, by Product Type
8.1.1. Dental Consumables
8.1.1.1. Market Revenue and Forecast
8.1.2. Dental Restoration
8.1.2.1. Market Revenue and Forecast
8.1.3. Orthodontics
8.1.3.1. Market Revenue and Forecast
8.1.4. Endodontics
8.1.4.1. Market Revenue and Forecast
8.1.4. Endodontics
8.1.4.1. Market Revenue and Forecast
8.1.4. Periodontics
8.1.4.1. Market Revenue and Forecast
8.1.4. Prosthodontics
8.1.4.1. Market Revenue and Forecast
8.1.4. Infection Control Products
8.1.4.1. Market Revenue and Forecast
8.1.4. Dental Equipment
8.1.4.1. Market Revenue and Forecast
8.1.4. Diagnostic Equipment
8.1.4.1. Market Revenue and Forecast
8.1.4. Therapeutic Equipment
8.1.4.1. Market Revenue and Forecast
8.1.4. General Equipment
8.1.4.1. Market Revenue and Forecast
8.1.4. Hygiene Maintenance Devices
8.1.4.1. Market Revenue and Forecast
8.1.4. Dental Materials
8.1.4.1. Market Revenue and Forecast
8.1.4. Filling Materials
8.1.4.1. Market Revenue and Forecast
8.1.4. Impression Materials
8.1.4.1. Market Revenue and Forecast
8.1.4. Cements and Bonding Agents
8.1.4.1. Market Revenue and Forecast
8.1.4. Dental Implants
8.1.4.1. Market Revenue and Forecast
8.1.4. Dental Software
8.1.4.1. Market Revenue and Forecast
8.1.4. Practice Management Software
8.1.4.1. Market Revenue and Forecast
8.1.4. Diagnostic Software
8.1.4.1. Market Revenue and Forecast
8.1.4. CAD/CAM Systems
8.1.4.1. Market Revenue and Forecast
9.1. Dental Market, by Treatment Type
9.1.1. Preventive
9.1.1.1. Market Revenue and Forecast
9.1.2. Restorative
9.1.2.1. Market Revenue and Forecast
9.1.3. Periodontics
9.1.3.1. Market Revenue and Forecast
9.1.4. Endodontics
9.1.4.1. Market Revenue and Forecast
9.1.4. Cosmetic
9.1.4.1. Market Revenue and Forecast
9.1.4. Others
9.1.4.1. Market Revenue and Forecast
10.1. Dental Market, by Age Group
10.1.1Paediatric Dentistry
10.1.1.1. Market Revenue and Forecast
10.1.2. Adult Dentistry
10.1.2.1. Market Revenue and Forecast
10.1.3. Geriatric Dentistry
10.1.3.1. Market Revenue and Forecast
11.1. Dental Market, by End-user
11.1.1. Dental Hospitals and Clinics
11.1.1.1. Market Revenue and Forecast
11.1.2. Dental Laboratories
11.1.2.1. Market Revenue and Forecast
11.1.3. Academic and Research Institutes
11.1.3.1. Market Revenue and Forecast
11.1.4. DSOs (Dental Service Organizations)
11.1.4.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product Type
12.1.2. Market Revenue and Forecast, by Treatment Type
12.1.3. Market Revenue and Forecast, by Age Group
12.1.4. Market Revenue and Forecast, by End-user
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product Type
12.1.5.2. Market Revenue and Forecast, by Treatment Type
12.1.5.3. Market Revenue and Forecast, by Age Group
12.1.5.4. Market Revenue and Forecast, by End-user
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product Type
12.1.6.2. Market Revenue and Forecast, by Treatment Type
12.1.6.3. Market Revenue and Forecast, by Age Group
12.1.6.4. Market Revenue and Forecast, by End-user
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product Type
12.2.2. Market Revenue and Forecast, by Treatment Type
12.2.3. Market Revenue and Forecast, by Age Group
12.2.4. Market Revenue and Forecast, by End-user
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product Type
12.2.5.2. Market Revenue and Forecast, by Treatment Type
12.2.5.3. Market Revenue and Forecast, by Age Group
12.2.5.4. Market Revenue and Forecast, by End-user
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product Type
12.2.6.2. Market Revenue and Forecast, by Treatment Type
12.2.6.3. Market Revenue and Forecast, by Age Group
12.2.6.4. Market Revenue and Forecast, by End-user
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product Type
12.2.7.2. Market Revenue and Forecast, by Treatment Type
12.2.7.3. Market Revenue and Forecast, by Age Group
12.2.7.4. Market Revenue and Forecast, by End-user
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product Type
12.2.8.2. Market Revenue and Forecast, by Treatment Type
12.2.8.3. Market Revenue and Forecast, by Age Group
12.2.8.4. Market Revenue and Forecast, by End-user
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product Type
12.3.2. Market Revenue and Forecast, by Treatment Type
12.3.3. Market Revenue and Forecast, by Age Group
12.3.4. Market Revenue and Forecast, by End-user
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product Type
12.3.5.2. Market Revenue and Forecast, by Treatment Type
12.3.5.3. Market Revenue and Forecast, by Age Group
12.3.5.4. Market Revenue and Forecast, by End-user
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product Type
12.3.6.2. Market Revenue and Forecast, by Treatment Type
12.3.6.3. Market Revenue and Forecast, by Age Group
12.3.6.4. Market Revenue and Forecast, by End-user
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product Type
12.3.7.2. Market Revenue and Forecast, by Treatment Type
12.3.7.3. Market Revenue and Forecast, by Age Group
12.3.7.4. Market Revenue and Forecast, by End-user
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product Type
12.3.8.2. Market Revenue and Forecast, by Treatment Type
12.3.8.3. Market Revenue and Forecast, by Age Group
12.3.8.4. Market Revenue and Forecast, by End-user
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product Type
12.4.2. Market Revenue and Forecast, by Treatment Type
12.4.3. Market Revenue and Forecast, by Age Group
12.4.4. Market Revenue and Forecast, by End-user
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product Type
12.4.5.2. Market Revenue and Forecast, by Treatment Type
12.4.5.3. Market Revenue and Forecast, by Age Group
12.4.5.4. Market Revenue and Forecast, by End-user
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product Type
12.4.6.2. Market Revenue and Forecast, by Treatment Type
12.4.6.3. Market Revenue and Forecast, by Age Group
12.4.6.4. Market Revenue and Forecast, by End-user
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product Type
12.4.7.2. Market Revenue and Forecast, by Treatment Type
12.4.7.3. Market Revenue and Forecast, by Age Group
12.4.7.4. Market Revenue and Forecast, by End-user
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product Type
12.4.8.2. Market Revenue and Forecast, by Treatment Type
12.4.8.3. Market Revenue and Forecast, by Age Group
12.4.8.4. Market Revenue and Forecast, by End-user
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product Type
12.5.2. Market Revenue and Forecast, by Treatment Type
12.5.3. Market Revenue and Forecast, by Age Group
12.5.4. Market Revenue and Forecast, by End-user
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product Type
12.5.5.2. Market Revenue and Forecast, by Treatment Type
12.5.5.3. Market Revenue and Forecast, by Age Group
12.5.5.4. Market Revenue and Forecast, by End-user
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product Type
12.5.6.2. Market Revenue and Forecast, by Treatment Type
12.5.6.3. Market Revenue and Forecast, by Age Group
12.5.6.4. Market Revenue and Forecast, by End-user
13.1. 3M (U.S.)
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Institut Straumann AG (Switzerland)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Henry Schein, Inc. (U.S.)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Angelalign Technology Inc. (China)
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. SHOFU INC. (Japan)
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Dentsply Sirona (U.S.)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Align Technology, Inc. (U.S.)
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Zimmer Biomet (U.S.)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Coltene (Switzerland)
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. BIOLASE, Inc. (U.S.)
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client